BCL2 and small cell lung carcinoma: Based on the aforementioned evidence and focusing on the anti-apoptotic BCL-2 family, we examined the anti-apoptotic BCL-2 family expression profile in SCLC patients and S63845 efficacy in SCLC cell lines.